Your browser doesn't support javascript.
loading
A prognostic model for overall survival in sporadic Creutzfeldt-Jakob disease.
Llorens, Franc; Rübsamen, Nicole; Hermann, Peter; Schmitz, Matthias; Villar-Piqué, Anna; Goebel, Stefan; Karch, André; Zerr, Inga.
Afiliação
  • Llorens F; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Barcelona, Spain.
  • Rübsamen N; Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Hermann P; Department of Neurology, University Medical School, Göttingen, Germany.
  • Schmitz M; Institute for Epidemiology and Social Medicine, University of Münster, Münster, Germany.
  • Villar-Piqué A; Department of Neurology, University Medical School, Göttingen, Germany.
  • Goebel S; Department of Neurology, University Medical School, Göttingen, Germany.
  • Karch A; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Barcelona, Spain.
  • Zerr I; Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Alzheimers Dement ; 16(10): 1438-1447, 2020 10.
Article em En | MEDLINE | ID: mdl-32614136
ABSTRACT

INTRODUCTION:

We developed a prognostic model for overall survival after diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD) using data from a German surveillance study.

METHODS:

We included 1226 sCJD cases (median age 66 years, range 19-89 years; 56.8% women with information on age, sex, codon 129 genotype, 14-3-3 in the cerebrospinal fluid (CSF), and CSF tau concentrations. The prognostic accuracy for overall survival was measured by the c statistics of multivariable Cox proportional hazard models. A score chart was derived to predict 6-month survival and median survival time.

RESULTS:

A model containing age, sex, codon 129 genotype, and CSF tau (with two-way interactions) was selected as the model with the highest c statistic (0.686, 95% confidence interval 0.665-0.707) in a cross-validation approach.

DISCUSSION:

We developed the first prognostic model for overall survival of sCJD patients based on readily available information only. The developed score chart serves as a hands-on prediction tool for clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Creutzfeldt-Jakob Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Creutzfeldt-Jakob Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article